CONTEXT - For many years, the detection of prostate cancer (PC) and the management of its therapy have been based primarily on prostate-specific antigen, rectal examination and prostate biopsy. However, these parameters have known limitations.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Multiparametric magnetic resonance imaging (mpMRI) for prostate cancer has undergone extensive development in recent years, providing morphological and functional information. The aim of this study is to present an updated review of the scope and limitations of prostatic mpMRI for PC, in the framework of a multidisciplinary vision.
ACQUISITION OF EVIDENCE - We conducted a literature review (in PubMed) of articles referencing "mpMRI/staging/ PC/detection/active surveillance/therapy planning/post-therapy". We included 4 systematic reviews and other articles published in high impact-factor journals within the field of radiology and urology.
SUMMARY OF THE EVIDENCE - MpMRI provides morphological and functional information concerning PC. This information is integrated into the Prostate Imaging Report and Date System, classifying the probability of clinically significant carcinoma on a scale from 1 to 5. The usefulness of mpMRI is currently being established for patients with high prostate-specific antigen levels and prior negative prostate biopsy; tumour staging in selected cases; assessment of patients who are candidates for active surveillance; the planning of focal treatments; and the assessment of tumour persistence and recurrence.
CONCLUSIONS - MpMRI currently fills a relevant role in the diagnosis and therapeutic decision-making of PC. More widespread use of the technique requires a cost/benefit analysis.
Actas urologicas espanolas. 2016 Feb 23 [Epub ahead of print]
V Catalá, D Salas, S Esquena, S Mateu, F Algaba, J Palou, P de la Torre
Servicio de Radiología e Intervencionismo, Fundació Puigvert, Barcelona, España. Servicio de Urología, Fundació Puigvert, Barcelona, España., Servicio de Urología, Fundació Puigvert, Barcelona, España., Coordinación de Investigación, Fundació Puigvert, Barcelona, España., Servicio de Anatomía Patológica, Fundació Puigvert, Barcelona, España., Servicio de Urología, Fundació Puigvert, Barcelona, España., Servicio de Radiología e Intervencionismo, Fundació Puigvert, Barcelona, España.